Literature DB >> 17260395

Muscle MRI in inherited neuromuscular disorders: past, present, and future.

Eugenio Mercuri1, Anna Pichiecchio, Joanna Allsop, Sonia Messina, Marika Pane, Francesco Muntoni.   

Abstract

Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an increasing number of genetic defects in the field of inherited neuromuscular disorders. Muscle ultrasound (US) and computed tomography (CT) have been used to detect the presence of muscle involvement in patients affected by these disorders, but until recently the use of muscle MRI has been, with a few exceptions, limited to detecting inflammatory forms. The aim of this review is to illustrate how muscle MRI, in combination with clinical evaluation, can contribute to the selection of appropriate genetic tests and more generally in the differential diagnosis of genetically distinct forms of neuromuscular disorders. Possible future applications of muscle MRI are also discussed. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17260395     DOI: 10.1002/jmri.20804

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  103 in total

Review 1.  Advanced MRI Techniques for Muscle Imaging.

Authors:  Vivek Kalia; Doris G Leung; Darryl B Sneag; Filippo Del Grande; John A Carrino
Journal:  Semin Musculoskelet Radiol       Date:  2017-08-03       Impact factor: 1.777

2.  MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies.

Authors:  R Stramare; V Beltrame; R Dal Borgo; L Gallimberti; A C Frigo; E Pegoraro; C Angelini; L Rubaltelli; G P Feltrin
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

Review 3.  Quantitative proton MR techniques for measuring fat.

Authors:  H H Hu; H E Kan
Journal:  NMR Biomed       Date:  2013-10-03       Impact factor: 4.044

4.  Vascular abnormalities correlate with decreased soft tissue volumes in idiopathic clubfoot.

Authors:  Laura J Merrill; Christina A Gurnett; Marilyn Siegel; Sushil Sonavane; Matthew B Dobbs
Journal:  Clin Orthop Relat Res       Date:  2010-11-02       Impact factor: 4.176

5.  European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

Authors:  Andrea Barp; Pascal Laforet; Luca Bello; Giorgio Tasca; John Vissing; Mauro Monforte; Enzo Ricci; Ariane Choumert; Tanya Stojkovic; Edoardo Malfatti; Elena Pegoraro; Claudio Semplicini; Roberto Stramare; Olivier Scheidegger; Jana Haberlova; Volker Straub; Chiara Marini-Bettolo; Nicoline Løkken; Jordi Diaz-Manera; Jon A Urtizberea; Eugenio Mercuri; Martin Kynčl; Maggie C Walter; Robert Y Carlier
Journal:  J Neurol       Date:  2019-09-25       Impact factor: 4.849

6.  Value of structured reporting in neuromuscular disorders.

Authors:  Francesco Alessandrino; Lara Cristiano; Claudia Maria Cinnante; Tommaso Tartaglione; Simonetta Gerevini; Tommaso Verdolotti; Giovanna Stefania Colafati; Emanuele Ghione; Raimondo Vitale; Lorenzo Peverelli; Claudia Brogna; Angela Berardinelli; Maurizio Moggio; Eugenio M Mercuri; Anna Pichiecchio
Journal:  Radiol Med       Date:  2019-03-09       Impact factor: 3.469

7.  Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Hyun Su Kim; Jae-Hun Kim; Byung-Ok Choi
Journal:  Eur Radiol       Date:  2020-10-30       Impact factor: 5.315

8.  Magnetic resonance imaging in muscular dystrophies.

Authors:  Luisa Politano; Giovanni Nigro
Journal:  Acta Myol       Date:  2015-12

9.  Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment.

Authors:  Hee Kyung Kim; Tal Laor; Paul S Horn; Brenda Wong
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

10.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.